A significant difference between two genotypes occur at stage 1, in which KRAS+ tumor cells displayed more normal nucleocytoplasmic ratios (Fig 2C and 2D), perhaps due to slightly larger cell size and smaller nuclei compared to EGFR+ cells (Fig 2D). The gene discussed is KRAS; the disease is neoplasm.